MEADVILLE, Pa., June 7, 2013 /PRNewswire/ -- C&J Industries, a leader in medical device contract manufacturing and plastic injection molding, has announced the completion of an additional expansion to its facilities as business continues to grow.
The Pennsylvania-based custom injection molding manufacturer has added four new all-electric Toshiba presses in the past two months, along with a new AGIE Charmilles FO550 Die-Sinking EDM machine. C&J Industries has invested over $10 million over the past four years in new capital equipment and expansion projects.
In 2011, C&J Industries completed a $6.8 million expansion and renovation project that became fully operational in January of 2012. With the recent purchase of $1.4 million in new equipment there are now 50 injection molding machines at the facilities that range from 20 tons to 720 tons of clamping pressure. C&J Industries currently has three Class VIII Clean Rooms for molding. It also has a 2,500-square-foot Class VII Clean Assembly Room for medical devices.
"This expansion was in response to double digit growth over the three previous years," said David Lennox, vice president of Operations for C&J Industries. "We believe much of our growth is tied to our unique mold warranty, which is 10 years for a production mold built by C&J Industries. This warranty provides a worry-free guarantee of uninterrupted production for medical and pharmaceutical customers."
The company has increased its operations in all market segments, including medical devices, telecommunications, industrial, consumer, pharmaceutical and transportation.
About C&J Industries: C&J Industries (http://www.cjindustries.com/) is a full-service pharmaceutical and medical contract device manufacturing firm specializing in plastic product design and development, custom contract medical device assembly and medical injection molding components. In business for 50 years, C&J is an industry leader in pharmaceutical and medical device contract manufacturing.
|SOURCE C&J Industries, Inc.|
Copyright©2012 PR Newswire.
All rights reserved